In the article by Duyckaerts, Charlesa; Clavaguera, Florenceb; Potier, Marie-Claudeb published in Current Opinion in Neurology (April 2019 - Volume 32 - Issue 2 - p 266-271) , taking the example of Alzheimer's and Parkinson's diseases, presents the experimental and human data that support the hypothesis that Aβ, tau, and α-synuclein may seed and...
Preliminary results from a feasibility study suggest a potential role for flavonoid enriched cocoa to treat fatigue, one of the most challenging symptoms of multiple sclerosis
Experts have already concluded that exercise can help people with Parkinson's disease improve their motor symptoms, but what is its effect on the cognitive symptoms of this condition?
Previously unseen oligodendrocyte dynamics and heterogeneity could limit remyelination in multiple sclerosis (MS), according to two new studies published in Nature. The findings could provide new therapeutic opportunities. Repair of myelin in demyelinating disease is thought to involve the generation of new oligodendrocytes. However, this view is...
Learning while asleep is a dream of mankind, but is often deemed impossible because sleep lacks the conscious awareness and neurochemical milieu thought to be necessary for learning. Current evidence for sleep learning in humans is inconclusive. To explore conditions under which verbal learning might occur, we hypothesized that peaks of slow waves...
Deposition of iron in the periaqueductal grey matter (PAG) is a potential biomarker for chronic migraine (CM), say researchers. Domínguez and co-workers used 3T MRI to analyse the deposition of iron in the red nucleus, globus pallidus and PAG of 55 patients with CM, 57 patients with episodic migraine (EM) and 25 controls. Patients with CM had...
A new study of fish oils and ischemic stroke that included data on adipose tissue levels of the key fatty acids has suggested a greater benefit with eicosapentaenoic acid (EPA) than with docosahexaenoic acid (DHA) or total fish oil intake.
Being overweight can lead to several health problems.
A blood test for a protein could identify people in the early stages of Alzheimer's disease a decade or more before symptoms, such as a decline in memory and thinking, emerge.
Quercetin is a flavonol, which is a sub-category of flavonoids.
